CV Advisors’s Bristol-Myers Squibb BMY Stock Holding History

CV Advisors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$691K	Buy	+12,000	New	+$689K	0.13%	70

Other funds holding BMY

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

ORIO

Old Republic International (ORI) Chicago, Illinois $2.67B AUM 26.94% 1-Year Est. Return

CV Advisors's BMY Position: Q2 2026 in Review

CV Advisors opened a new position in Bristol-Myers Squibb (BMY) in Q2 2026: 12,000 shares worth $691K. The stake represents 0.13% of the portfolio and ranks #70 among its holdings.

597 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

CV Advisors held 12,000 shares of Bristol-Myers Squibb worth $691K as of Q2 2026.
Bristol-Myers Squibb was a new CV Advisors position in Q2 2026.
Bristol-Myers Squibb made up 0.13% of CV Advisors's portfolio in Q2 2026, its #70 holding.
597 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on CV Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.